Literature DB >> 8020880

Prognostic significance of diabetes in patients with cirrhosis.

G Bianchi1, G Marchesini, M Zoli, E Bugianesi, A Fabbri, E Pisi.   

Abstract

Alterations in carbohydrate metabolism are frequently observed in cirrhosis, and approximately 15% to 30% of patients have overt diabetes. In a retrospective and prospective study in cirrhosis, we analyzed the prognostic significance of diabetes, which was defined as the presence of hyperglycemia and overt glycosuria that in most cases required dietary restrictions or active treatment. The clinical records of all patients with cirrhosis admitted to our department for the period 1980 to 1985 were reviewed in 1985 and 1986, and surviving patients were prospectively followed up until December 1991. Final status could be obtained in 354 (98 with diabetes) of 382 eligible patients; 110 were alive at the end of follow-up. Prognostic factors were identified by Kaplan-Meier analysis, followed by Cox's stepwise regression. The model identified, in sequence, albumin, ascites, age, encephalopathy, bilirubin, diabetes, and platelets as prognostic factors. The larger mortality rate in patients with diabetes was not due to complications of diabetes but to an increased risk of hepatocellular failure. Diabetes was no longer a risk factor as a covariate in a subgroup of 271 patients when varices were added but was again significant when patients who died of gastrointestinal bleeding were excluded. The presence of diabetes, clinically detectable and often requiring adequate treatment, is a risk factor for long-term survival in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020880     DOI: 10.1016/0270-9139(94)90143-0

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

Review 1.  NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Authors:  Elisabetta Bugianesi; Ester Vanni; Giulio Marchesini
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

Review 2.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

3.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

4.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

5.  Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

Authors:  Tsai-Ling Liu; Justin Trogdon; Morris Weinberger; Bruce Fried; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 6.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 7.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

8.  Factors determining the clinical outcome of acute variceal bleed in cirrhotic patients.

Authors:  Shahid Majid; Zahid Azam; Hasnain Ali Shah; Mohammad Salih; Saeed Hamid; Shahab Abid; Wasim Jafri
Journal:  Indian J Gastroenterol       Date:  2009-11-12

Review 9.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.